Every time a woman is tested for gene mutations linked to significantly higher rates of breast and ovarian cancer, her blood is sent to a lab in Utah.
That’s because Salt Lake City-based Myriad Genetics Inc. owns the patents to the BRCA 1 and BRCA 2 mutations, giving it control over all research and testing done nationwide. The company charges thousands of dollars for each set of results.
View the original article here: Gene patent case could impact patients, research
 |
Infographics | More... |
Is tilapia a human-made freak that we should avoid — or an evolutionary rockstar? 
Embryos aren’t female by ‘default’ after all, study shows 
Viewpoint: The organic food industry is a $180 billion marketing fraud 
Viewpoint: Should you be concerned when you read that a chemical in your food has been linked to cancer? Here’s an epidemiologist’s checklist to detect over-hyped scares 
AMP v. Myriad Genetics: Do intellectual property protections really stifle innovation? 
Many high-functioning psychopaths live amongst us 
Many animals can walk at birth. Why are human babies born with so few skills? 
Viewpoint: Sri Lanka’s ‘tragic’ legacy — To encourage sustainable farming, countries cannot ignore food production and socioeconomic trade-offs 
Why humans have larger penises and smaller testicles than other great apes 
How Wegovy and Ozempic could transform our food systems 
